Fertilizers and Agricultural Chemicals

N2OFF

N2OFF released FY2025 9 Months Earnings on November 13 Post-Market (EST), actual revenue USD 68K, actual EPS USD -8.4682

N2OFF released FY2025 Q3 earnings on November 13, 2025, EST with actual revenue of USD 2 K and EPS of USD 0.4547

N2OFF Inc. plans to hold an annual shareholders' meeting and discuss multiple resolutions

N2OFF Completes $700,000 Merger with MitoCareX

N2OFF released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0, actual EPS USD -0.1811

N2OFF released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 66K, actual EPS USD -18.8322

N2off Inc. Extends Exclusive Period for Acquisition of MitoCareX Bio Ltd.

N2OFF released FY2025 Q1 earnings on May 15 (EST), actual revenue USD 66K, actual EPS USD -2.5822

N2OFF, Inc. Enters Polish Renewable Energy Market

N2OFF Announces Entry into Poland's Renewable Energy Market

N2OFF released FY2024 Annual Earnings on March 31 (EST), Actual Revenue USD 210K (Forecast USD 8.34M), Actual EPS USD -31.0892

N2OFF released FY2024 Q4 earnings on March 31 (EST), actual revenue USD 140.52K, actual EPS USD -4.2992

N2OFF Signs Letter of Intent with SB Impact 4 and Solterra to Develop Battery Storage Projects

N2OFF Granted 180-Day Extension by NASDAQ to Regain Compliance with Minimum Bid Price Rule

N2OFF released FY2024 Q3 earnings on November 14 EST, actual revenue USD 9K, actual EPS USD -13.5974

N2OFF released FY2024 9 Months Earnings on November 14 EST, actual revenue USD 70K, actual EPS USD -30.7778

N2OFF released FY2024 Q2 earnings on August 14 (EST), actual revenue USD 17 K, actual EPS USD -8.0804

N2OFF released FY2024 Semi-Annual earnings on August 14 (EST), actual revenue USD 60.55K, actual EPS USD -0.4889

N2OFF released FY2024 Q1 earnings on May 15 (EST), actual revenue USD 44K, actual EPS USD -9.1

N2OFF released FY2023 Q4 earnings on April 1, 2024 (EST), actual revenue USD 105.38K, actual EPS USD -34.8365

Micware

Silexion Therapeutics

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

GCL Global

Jupiter Neurosciences

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

HCW Biologics

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Arcadia Biosciences

SHOP

NITO

SHPU

As geopolitical tensions and fluctuating energy prices impact the STOXX Europe 600 Index, investors are focusing on high-growth tech stocks. Notable companies include Knowit, RaySearch Laboratories, and Shoper, each demonstrating resilience and potential for future growth despite market uncertainties. Knowit aims for profitability with a projected earnings growth of 76.5%, RaySearch showcases a 12.4% annual growth in earnings, and Shoper reports significant revenue and net income growth. These companies are positioned to capitalize on emerging tech opportunities in a challenging economic landscape.

Simplywall

Shopify 

Raytech

Direxion Daily SHOP Bull 2X ETF

High Growth Tech Stocks to Watch in March 2026

N2OFF shares are trading higher after the company announced a corporate rebranding to Nexentis Technologies and change in the trading symbol to NXTS on the Nasdaq.

benzinga_article

NXTS

N2OFF fell 10.66%; Kediwa Agricultural Technology fell 0.11%, with a transaction volume of USD 146 million; Meisheng fell 2.77%, with a transaction volume of USD 110 million; CF Industries fell 1.22%, with a transaction volume of USD 943.8 million; Nutrien rose 0.46%, with a market value of USD 34.6 billion

Price Alert

Nexentis Tech

U.S. stock market midday update: N2OFF drops over 10% with a surge in trading volume, market sentiment fluctuations attract attention

ACLX

BHAT

Overview of the US Stock Market The current market shows a clear trend of differentiation, with technology stocks and biotechnology stocks performing particularly well. The strong rise of Arcellx has attracted market attention, with an increase of 77.55% and significantly expanded trading volume, indicating active capital involvement. Meanwhile, Signing Day Sports also performed well, with an increase of 54.44%, achieving an astonishing rise of 315.18% in just 10 days, attracting a large amount of short-term capital. Overall, market sentiment is leaning towards active, with a noticeable increase in short-term enthusiasm. The most volatile stock in the last hour, Arcellx (ACLX), performed impressively in trading, with an increase of 77.55% and a significant increase in trading volume, showing strong capital demand. The strong performance of this stock seems to have driven the overall rise of the biotechnology sector, with market sentiment soaring. Strong stocks: 1. Guardforce AI (GFAI): up 29.02%, with significantly increased trading volume, and the market is full of expectations for its future development. 2. VenHub Global (VHUB): up 25.63%, with noticeable capital inflow and continued short-term enthusiasm. 3. Global Interactive Tech (GITS): up 22.76%, with increased recent activity attracting a lot of short-term capital

- The US stock market is currently exhibiting a clear trend of differentiation, particularly within technology and biotechnology sectors.  
- Notable performers include Arcellx, which rose by 77.55%, and Signing Day Sports, surging by 54.44%, attracting significant short-term investments.  
- Conversely, several stocks are under pressure, with Blue Hat dropping 46.28%, indicating a downturn in market sentiment.

Arcellx

Signing Day Sports

Blue Hat Interactive Ent Tech

20/20 Biolabs

Novabay Pharmac

WeShop

Gen Digital - Rights

Guardforce AI

VenHub Global

Real Messenger

Abits

Global Interactive Tech

Diginext

Clean Energy Tech

Park Ha Biological Tech

Star Fashion Culture

Planet Green

Beneficient

Lavoro

Neo-Concept

Starfighters Space

Tandem Diabetes

Zeo Energy

Novo Nordisk AS

Algorhythm

Baiya

Antelope Enterprise

Founder

Atomera

Profusa

Homestolife

DevvStream

Knorex

Edesa Biotech

ImmunityBio

DirectBooking Tech

Oriental Culture

Interactive Strength

Critical Metals

Smart Logistics Global

Troops

Ringcentral

Planet Image

GIBO

Solana

CVRx

MongoDB

Faraday Future Intelligent Electric

Rich Sparkle

Namib Minerals

Everbright Digital

Nasus Pharma

Datadog

Cogent Communications

TRAILBLAZER MERGER CORP I USD0.0001 CL A (S/R21/04/2028)

CrowdStrike

Purple Biotech

Mangoceuticals

KLX Energy Services

DNOW

Harmony Biosciences

Zscaler

Advanced Biomed

Evolution Metals & Tech

AIOS Tech

AppLovin

Direct Digital

Snowflake

Satellogic

Brand Engagement Network

TMD Energy

Regencell Bioscience

CloudFlare

Wayfair

Apimeds Pharmaceuticals US

Anghami

XChange Tec.Inc

SABRE

Opendoor Tech Series K - CW26

Olenox Industries

Atlassian

Funko

NuScale Power

AST SpaceMobile

Dermata Therapeutics

Expedia

Rackspace Tech

Monday.com

Workday

Pegasystems

American Express

Off The Hook YS

Capital One Financial

Zoom Communications

US Stock Movement Update: Arcellx surged 77.55%, Signing Day Sports rose 54.44%, Blue Hat Interactive Ent Tech fell 46.28%

N2OFF, Inc. has issued an early warning disclosure as required by National Instrument 62-103 due to a change in its ownership stake in Plantify Foods, Inc. Following a Private Placement on February 18, 2026, N2OFF's ownership decreased from approximately 23.6% to 9% of Plantify's outstanding shares, a reduction of about 14.6%. N2OFF may acquire or dispose of additional securities in the future. The early warning report is available on SEDAR+ and from Plantify's CFO.

The newswire.ca

N2OFF, Inc. Provides Early Warning Disclosure

SBIO

MitoCareX Bio, a subsidiary of N2OFF, Inc., reported successful in vitro results showing that its MITOLINE™-powered small molecules can inhibit pro-inflammatory responses in human immune cells. This breakthrough targets inflammatory metabolic diseases, a market projected to exceed $120 billion by 2030. The company plans to advance its promising candidates toward pre-clinical studies while expanding its discovery engine. The anti-inflammatory drug market is expected to grow significantly, highlighting the demand for targeted therapies in this therapeutic area.

StockTitan

Invesco Biotechnology & Genome ETF

Proshares Ultra Nasdaq Biotech

First Trust NYSE Arca Biotech Index Fd

VanEck Biotech ETF

SPDR S&P Biotech

iShares Biotechnology ETF

ALPS Medical Breakthrough

MitoCareX Bio Reports Successful Results in Vitro: MITOLINE™-Powered Small Molecules Show Anti-Inflammatory Potential for Metabolic Syndrome-Related Diseases | NITO Stock News